MLH1 and colonic neoplasm: Accordingly, the cisplatin resistance of human ovarian or colon cancer cell xenografts, which have hypermethylation of the MLH1 gene promoter, grown in nude mice was overcome when the cells were inoculated with the demethylating agent 2'-deoxy-5-azacytidine (DAC) and the mice were treated with cisplatin 36.